Image quality and dose reduction opportunity of deep learning image reconstruction algorithm for CT: a phantom study.


Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 06 11 2019
accepted: 05 02 2020
revised: 31 01 2020
pubmed: 27 2 2020
medline: 1 12 2020
entrez: 27 2 2020
Statut: ppublish

Résumé

To assess the impact on image quality and dose reduction of a new deep learning image reconstruction (DLIR) algorithm compared with a hybrid iterative reconstruction (IR) algorithm. Data acquisitions were performed at seven dose levels (CTDI NPS peaks were higher with AV50 than with all DLIR levels and only higher with DLIR-H than with AV100. The average NPS spatial frequencies were higher with DLIR than with IR. For all DLIR levels, TTF New DLIR algorithm reduced noise and improved spatial resolution and detectability without changing the noise texture. Images obtained with DLIR seem to indicate a greater potential for dose optimization than those with hybrid IR. • This study assessed the impact on image quality and radiation dose of a new deep learning image reconstruction (DLIR) algorithm as compared with hybrid iterative reconstruction (IR) algorithm. • The new DLIR algorithm reduced noise and improved spatial resolution and detectability without perceived alteration of the texture, commonly reported with IR. • As compared with IR, DLIR seems to open further possibility of dose optimization.

Identifiants

pubmed: 32100091
doi: 10.1007/s00330-020-06724-w
pii: 10.1007/s00330-020-06724-w
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3951-3959

Auteurs

Joël Greffier (J)

Department of Medical Imaging, CHU Nimes, Medical Imaging Group Nimes, Univ Montpellier, EA 2415, Bd Prof Robert Debré, 30029, Nîmes Cedex 9, France. joel.greffier@chu-nimes.fr.
Department of Medical Physics, CHU Nimes, Univ Montpellier, Montpellier, France. joel.greffier@chu-nimes.fr.

Aymeric Hamard (A)

Department of Medical Imaging, CHU Nimes, Medical Imaging Group Nimes, Univ Montpellier, EA 2415, Bd Prof Robert Debré, 30029, Nîmes Cedex 9, France.

Fabricio Pereira (F)

Department of Medical Imaging, CHU Nimes, Medical Imaging Group Nimes, Univ Montpellier, EA 2415, Bd Prof Robert Debré, 30029, Nîmes Cedex 9, France.

Corinne Barrau (C)

Department of Medical Physics, CHU Nimes, Univ Montpellier, Montpellier, France.

Hugo Pasquier (H)

GE Healthcare, Buc, France.

Jean Paul Beregi (JP)

Department of Medical Imaging, CHU Nimes, Medical Imaging Group Nimes, Univ Montpellier, EA 2415, Bd Prof Robert Debré, 30029, Nîmes Cedex 9, France.

Julien Frandon (J)

Department of Medical Imaging, CHU Nimes, Medical Imaging Group Nimes, Univ Montpellier, EA 2415, Bd Prof Robert Debré, 30029, Nîmes Cedex 9, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH